Amy Flynt

Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study

Sameera R. Wijayawardana, Ravi Salgia, R. Salgia, 2017, Investigational New Drugs.